Inflammatory Bowel Disease and Colorectal Cancer
Cancers · 23.08.2024 · 16 (17) · 2943
DOI: 10.3390/cancers16172943 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.08.2024. Verfasst von Jacopo Fanizza und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, 20132 Milan, Italy. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Patients with inflammatory bowel diseases (IBDs), including both ulcerative colitis (UC) and Crohn’s disease (CD), are at a higher risk of developing colorectal cancer (CRC). However, advancements in endoscopic imaging techniques, integrated surveillance programs, and improved medical therapies have led to a decrease in the incidence of CRC among IBD patients. Currently, the management of patients with IBD who have a history of or ongoing active malignancy is an unmet need. This involves balancing the risk of cancer recurrence/progression with the potential exacerbation of IBD if the medications are discontinued. The objective of this review is to provide an updated summary of the epidemiology, causes, risk factors, and surveillance approaches for CRC in individuals with IBD, and to offer practical guidance on managing IBD patients with history of previous or active cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, 20132 Milan, Italy.
- IBD Unit, Department of Gastroenterology and Digestive Endoscopy, San Camillo-Forlanini Hospital, 00152 Rome, Italy.
- Department of Gastroenterology, Nancy University Hospital, F-54500 Vandœuvre-lès-Nancy, France.
- INSERM, NGERE, University of Lorraine, F-54000 Nancy, France.
- INFINY Institute, Nancy University Hospital, F-54500 Vandœuvre-lès-Nancy, France.
- FHU-CURE, Nancy University Hospital, F-54500 Vandœuvre-lès-Nancy, France.
ORCID-Profile: Sarah Bencardino, Gionata Fiorino, Silvio Danese, Ferdinando D'Amico
Zitieren
APA
Fanizza, J., Bencardino, S., Allocca, M., Furfaro, F., Zilli, A., Parigi, T. L., Fiorino, G., Peyrin-Biroulet, L., Danese, S., & D'Amico, F. (2024). Inflammatory Bowel Disease and Colorectal Cancer. Cancers, 16(17), 2943. https://doi.org/10.3390/cancers16172943
Vancouver
Fanizza J, Bencardino S, Allocca M, Furfaro F, Zilli A, Parigi TL, et al. Inflammatory Bowel Disease and Colorectal Cancer. Cancers. 2024;16(17):2943. doi:10.3390/cancers16172943
BibTeX
@article{Fanizza2024,
author = {Fanizza, Jacopo and Bencardino, Sarah and Allocca, Mariangela and Furfaro, Federica and Zilli, Alessandra and Parigi, Tommaso Lorenzo and Fiorino, Gionata and Peyrin-Biroulet, Laurent and Danese, Silvio and D'Amico, Ferdinando},
title = {Inflammatory Bowel Disease and Colorectal Cancer},
journal = {Cancers},
year = {2024},
volume = {16},
number = {17},
pages = {2943},
doi = {10.3390/cancers16172943}
}
EUVIMED